
How much is thcx stock worth?
One share of THCX stock can currently be purchased for approximately C$5.30. How much money does Hydropothecary make? Hydropothecary has a market capitalization of C$949.11 million.
What is the thcx?
Listed on New York Stock Exchange's Archipelago Exchange, the THCX tracks the Innovation Labs Cannabis Index, a portfolio of 33 stocks that are expected to benefit from the growth of the legal global marijuana, cannabinoid and hemp industries.
Is Hydropothecary (thcx) a good buy?
Hydropothecary has received 72.31% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Hydropothecary and other stocks. Vote “Outperform” if you believe THCX will outperform the S&P 500 over the long term.
Will thcx outperform or underperform the S&P 500 over the long term?
Vote “Outperform” if you believe THCX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe THCX will underperform the S&P 500 over the long term. You may vote once every thirty days. Hydropothecary does not currently pay a dividend. Hydropothecary does not have a long track record of dividend growth.

Will THCX go up?
Is THCX stock going to rise? Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THCX is experiencing slight selling pressure.
Is THCX a buy or sell?
A sell signal was issued from a pivot top point on Friday, March 25, 2022, and so far it has fallen -33.50%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive.
What companies are in the THCX ETF?
Top 10 HoldingsCompanySymbolTotal Net AssetsOrganiGram Holdings Inc.OGI12.13%Cronos Group Inc.CRON11.74%Canopy Growth Corp.CGC10.54%Aurora Cannabis Inc.ACB10.52%6 more rows
Will medipharm Labs bounce back?
While there is no evidence of a comeback just yet, we will follow the stock and its progress throughout 2021.
Is THCX actively managed?
Yes, the fund is passively managed and tracks the Innovation Labs Cannabis Index. The Bloomberg ticker for the index is “THCX Index”.
Is there a CBD ETF?
7 best marijuana ETFs to buy in 2022: AdvisorShares Pure U.S. Cannabis ETF (MSOS) ETFMG Alternative Harvest ETF (MJ) AdvisorShares Pure Cannabis ETF (YOLO)
What is company THCX?
Listed on the NYSE, the Cannabis ETF (THCX) is an ETF that provides investors with a liquid and diversified vehicle to gain access to the growth of the legal cannabis market.
What stocks are in Toke ETF?
Cannabis (TOKE) - Full HoldingsPERCENTAGE OF NET ASSETSNAMESHARES HELD10.51%Innovative Industrial Properties Inc.12,2865.41%Jazz Pharmaceuticals PLC7,5170.30%MediPharm Labs Corp.616,0801.11%Neptune Wellness Solutions Inc.762,84023 more rows
Should I sell MediPharm Labs stock?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MediPharm Labs in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MediPharm Labs stock.
Is MediPharm Labs a good investment?
MediPharm Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Will MediPharm stock go up?
MediPharm Labs Corp. quote is equal to 3.520 USD at 2022-05-31. Based on our forecasts, a long-term increase is expected, the "MLCPF" stock price prognosis for 2024-04-03 is 16.917 USD. With a 5-year investment, the revenue is expected to be around +380.59%.
What other stocks do shareholders of Innovation Shares Cannabis ETF own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Innovation Shares Cannabis ETF investors own include ETFMG...
What is Innovation Shares Cannabis ETF's stock symbol?
Innovation Shares Cannabis ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "THCX."
Who are Innovation Shares Cannabis ETF's major shareholders?
Innovation Shares Cannabis ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Cutler Gr...
Which institutional investors are selling Innovation Shares Cannabis ETF stock?
THCX stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP.
How do I buy shares of Innovation Shares Cannabis ETF?
Shares of THCX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Innovation Shares Cannabis ETF's stock price today?
One share of THCX stock can currently be purchased for approximately $4.88.
How much money does Innovation Shares Cannabis ETF make?
Innovation Shares Cannabis ETF has a market capitalization of $40.99 million.
Who are Hydropothecary's key executives?
Hydropothecary's management team includes the following people: Mr. Sebastien G. St-Louis , Co-Founder, Pres, CEO & Director (Age 34) Mr. Adam M...
Who are some of Hydropothecary's key competitors?
Some companies that are related to Hydropothecary include Evotec (EVT) , Canopy Growth (WEED) , Aurora Cannabis (ACB) , Knight Therapeutics (GU...
What other stocks do shareholders of Hydropothecary own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Hydropothecary investors own include Aurora Cannabis (ACB)...
What is Hydropothecary's stock symbol?
Hydropothecary trades on the Canadian Venture Exchange (CVE) under the ticker symbol "THCX."
How do I buy shares of Hydropothecary?
Shares of THCX and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadia...
What is Hydropothecary's stock price today?
One share of THCX stock can currently be purchased for approximately C$5.30.
How much money does Hydropothecary make?
Hydropothecary has a market capitalization of C$949.11 million.
What is Hydropothecary's official website?
The official website for Hydropothecary is www.thehydropothecary.com .
Where are Hydropothecary's headquarters?
Hydropothecary is headquartered at 120 Ch de la Rive, GATINEAU, QC J8M 1V2, Canada .
How much is the cannabis ETF 2021?
The The Cannabis ETF price gained 2.30% on the last trading day (Friday, 9th Jul 2021), rising from $16.07 to $16.44. During the day the ETF fluctuated 2.24% from a day low at $16.08 to a day high of $16.44. The price has fallen in 8 of the last 10 days and is down by -5.41% for this period. Volume fell on the last day by -50 thousand shares and in total, 39 thousand shares were bought and sold for approximately $637.84 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Is cannabis gaining volume on the last day?
The Cannabis gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Does the cannabis ETF have a sell signal?
The The Cannabis ETF holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the ETF giving a more negative forecast for the stock. On further gains, the ETF will meet resistance ...
What is CFN media?
CFN Media spearheads the launch of a single unified digital outreach program that attracts and engages both retail and institutional investors active in cannabis. Whitefish, Montana-- (Newsfile Corp. - March 24, 2021) - CFN Enterprises Inc. (OTCQB: CNFN) owner and operator of CFN Media, the leading agency and media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced the launch of a unified digital outreach program with Intro-act, Inc. that streamlines efforts required by top tier ...
What is an ETF in marijuana?
Marijuana exchange-traded funds (ETFs) provide investors with exposure to equities of companies that engage in the cultivation, distribution, and sale of marijuana and related products. Products of marijuana companies include dried flowers, oils, seeds, edibles, and more.
What is high tide in stock?
("High Tide" or the "Company") (TSXV: HITI) (OTCQB: HITID) (FRA:2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, is pleased to announce today that it has been added to the Cannabis ETF (NYSE: THCX) (the "THCX"). Listed on New York Stock Exchange's Archipelago Exchange, the THCX tracks the Innovation Labs Cannabis Index, a portfolio of 33 stocks that are expected to benefit from the growth of the legal global marijuana, cannabinoid and hemp industries.
How much is Curaleaf's revenue in 2021?
Curaleaf Holdings Inc.'s stronger-than-expected first-quarter earnings have put the company on track to deliver above-consensus numbers for 2021 and beat its own guidance for full-year revenue of $1.2 billion to $1.3 billion, analysts said Tuesday.
Is Nova Cannabis a THC ETF?
Nova Cannabis Inc. (the "Company" or "Nova") (TSXV: NOVC), is pleased to announce today that it has been added to the Cannabis ETF (NYSE: THCX) ("THCX"), an exchange traded fund listed on the NYSE Arca.
Has the Senate Banking Committee made a decision yet?
The chairman of the Senate Banking Committee said no decision had been made yet on how a House-passed bill to help cannabis-based businesses get access to the banking system would advance in the Senate.
Who is Isaac Boltansky?
Isaac Boltansky, director of policy research at Compass Point Research & Trading , joins Yahoo Finance Live to discuss the winners and losers in different electoral scenarios from the Georgia Senate runoff, as well as the three areas he’s focused on from President-elect Joe Biden’s agenda. #N#. #N#. #N#. #N#.
Who are some of Hydropothecary's key competitors?
Some companies that are related to Hydropothecary include Aurora Cannabis (ACB), Knight Therapeutics (GUD), OrganiGram (OGI), HLS Therapeutics (HLS), Amryt Pharma (AMYT), Benchmark (BMK), HEXO (HEXO), Supreme Cannabis (FIRE), ESSA Pharma (EPI), ICC Labs (ICC), Leaf Mobile (LEAF), Medexus Pharmaceuticals (MDP), BioSyent (RX), Diurnal Group (DNL) and Green Organic Dutchman (TGOD). View all of THCX's competitors..
What other stocks do shareholders of Hydropothecary own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Hydropothecary investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), (CGC), Cronos Group (CRON), CannTrust (CTST), Funko (FNKO), (HEXO), Riot Blockchain (RIOT) and Unrivaled Brands (TRTC).
What is Hydropothecary's stock symbol?
Hydropothecary trades on the Canadian Venture Exchange (CVE) under the ticker symbol "THCX."
How do I buy shares of Hydropothecary?
Shares of THCX and other Canadian stocks can be purchased through an online brokerage account.
What is Hydropothecary's stock price today?
One share of THCX stock can currently be purchased for approximately C$5.30.
Where are Hydropothecary's headquarters?
Hydropothecary is headquartered at 120 Ch de la Rive, GATINEAU, QC J8M 1V2, Canada.
How can I contact Hydropothecary?
Hydropothecary's mailing address is 120 Ch de la Rive, GATINEAU, QC J8M 1V2, Canada. The company can be reached via phone at +1-416-7504949.
Investment Information THCX
The Fund seeks total return performance of the Innovation Labs Cannabis Index. The Fund invests in the component securities of the Index and the Fund also invests at least 80% of its net assets in exchange listed common stock (or corresponding American Depositary Receipts (ADRs) of Cannabis Companies.
Distribution History THCX
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements. Fundamental company data and analyst estimates provided by FactSet.
